A new approach in anticancer vaccine development shows early success in targeting neuroblastoma
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Jun-2026 17:15 ET (21-Jun-2026 21:15 GMT/UTC)
Researchers from have identified several modifiable factors that influence psychological resilience in female athletes and found that greater resilience may help protect against depression, anxiety, post-traumatic stress disorder (PTSD) and high levels of perceived stress.
The findings, “Modifiable Risk Factors of Female Athlete Psychological Resilience and Mental Health: A Longitudinal Investigation,” published in Sport, Exercise, and Performance Psychology, provide new insight into how resilience develops over time and offer a roadmap for future interventions designed to support the mental health and well-being of female athletes.
The study from researchers at LSU’s Pennington Biomedical Research Center, Harvard Medical School, Trinity University, Michigan State University and Women’s Health, Sports and Performance Institute in Boston followed close to 400 female athletes from across the United States over a 12-month period. Researchers examined factors that could influence resilience, including emotion regulation, sleep quality, social support, experiential avoidance and intolerance of uncertainty. They also evaluated how resilience affected mental health outcomes over time.
Immunotherapies are a promising approach in the fight against cancer. Researchers at the Technical University of Munich (TUM) have developed a lab-on-a-chip system called CellTrap. It makes it possible to observe the interactions between immune cells and cancer cells at the single-cell level. The method is intended to help better understand fundamental processes in cancer immunology and answer key questions.
New research links childhood adversity to mitochondrial bioenergetic changes later in life, underscoring the impact of stress in early life on cellular health. The study also found that different types of childhood stressors leave unique biological signatures. The findings in Biological Psychiatry, published by Elsevier, add to our understanding of how early-life adversity can impact mental and physical health across the lifespan, informing screening and intervention efforts.
People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a person carries, but also on how they are “read”. By changing the epigenetic reading signals in the thin fat layer surrounding arteries and veins, researchers led by the University of Zurich were able to reduce inflammation and improve blood vessel health in both mice and human tissue.
Led by Dr. Alex Zhavoronkov, Founder, CEO, and CBO of Insilico Medicine, the Insilico Medicine team will meet with biopharma partners, investors, and researchers at Booth #4021 to explore collaboration opportunities. Insilico Medicine will showcase the core capabilities of its end-to-end Pharma.AI platform as well as its latest R&D pipeline.